Saturday, March 6, 2021

Tag: Diabetes

Promise of stem cells fulfilled

Published: November 6, 2010

clinical trial in Atlanta, Georgia, is proof that informed public debate is the key to medical advance

IF I’m honest, my first reaction to recent reports that the first human embryonic stem cell trial had begun on spinal patients in Atlanta was one of nonchalance.

Not because of its potential significance to those of us with spinal injuries — desperate for any news of progress — but because of the stop-start nature of the trial, plagued as it has been by legislative and regulatory restraints.

Geron Starts First Human Embryonic Stem-Cell Study

Published: October 11, 2010

Oct. 11 (Bloomberg) — Geron Corp. used a therapy made from stem cells taken from human embryos to treat a patient paralyzed by a spinal-cord injury in the first U.S.-authorized test of the technology.

The patient was treated Oct. 8 at Shepherd Center, a rehabilitation hospital in Atlanta, the company said today in a statement. The study is designed to test the safety of Geron’s therapy in patients with spinal cord injuries. The U.S. Food and Drug Administration gave permission in July for Geron to start the study after a halt of almost a year over safety concerns.

Second anniversary of Michigan embryonic stem cell research vote

Published: October 4, 2010

On Oct 4-6, Michigan welcomes the World Stem Cell Summit. Honored at the conference are Governor Jennifer Granholm and Alfred Taubman. Dr. Joseph Kincaid of Right to Life responds.

On November 4, 2008, Michigan voters, by a narrow margin, passed Proposal 2. Proposal 2 became an amendment to our Constitution that permitted unused human embryos in our in vitro fertilization clinics to be destroyed and their embryonic stem cells (ESC) used for research. The hopes were that this research would lead to cures for diseases devastating our society such as spinal cord injuries, diabetes, heart disease, Alzheimer’s, Parkinsonism, etc.

Appeals court grants stay in stem cell case

Published: September 10, 2010

The federal government will be allowed to keep funding stem cell research — for now.

An Aug. 23 ruling by a U.S. District Court judge barred federal funding of such research until an appeals court granted a stay Thursday that will allow the government to provide money until the case is heard before a federal appeals court, a process that could take several months.

U.S. District Judge Royce Lamberth cited the Dickey-Webber amendment, a federal law that prohibits the use of federal funding for any research in which human embryos may be destroyed.

National Institutes of Health Director Francis S. Collins said in a statement after the initial ruling that the freezing of federal funding greatly threatens current research.

Effect on stem cell ruling on companies unclear

Published: August 25, 2010

(Reuters) – Government officials say they will appeal a U.S. District Court injunction that stops new federal funding of human embryonic stem cell research.

The ruling has no direct effect on researchers or companies working with private funds, but government funding often kick-starts the most basic, and risky biological work.

Scientists are working to use them to repair severed spinal cords, regenerate brain cells lost in Parkinson’s disease and restore the tissue destroyed by juvenile diabetes.

Court Blocks New Federal Funding for Embryonic Stem Cell Research

Published: August 23, 2010

A federal judge temporarily blocked the Obama administration Monday from using federal dollars to fund expanded human embryonic stem cell research, saying the research involves the destruction of embryos.

The ruling comes after the National Institutes of Health last year issued new guidelines permitting federal funding for research on certain stem cell lines that had already been created.

Adult stem cell research far ahead of embryonic

Published: August 2, 2010

NEW YORK — A few months ago, Dr. Thomas Einhorn was treating a patient with a broken ankle that wouldn’t heal, even with multiple surgeries. So he sought help from the man’s own body.

Einhorn drew bone marrow from the man’s pelvic bone with a needle, condensed it to about four teaspoons of rich red liquid, and injected that into his ankle.

Four months later the ankle was healed. Einhorn, chairman of orthopedic surgery at Boston University Medical Center, credits “adult” stem cells in the marrow injection. He tried it because of published research from France.

With U.S. stem cell treatments limited, patients try other countries

Published: June 6, 2010

Disillusioned by U.S. doctors who could not help their daughter with cerebral palsy, Kara Anderson’s parents did something they could not have imagined a few years ago: They took her to China.

Specialists in the Chicago area, where the family lives, said that Kara’s brain injury was permanent and that the 9-year-old would probably end up in a wheelchair because of severe twisting in her leg muscles. But then her parents heard stories about children who had improved after receiving injections of stem cells.

The treatment was not available in the United States. It was only commercially available abroad.

Safety Follow-up of Adult Stem Cell Patients Yields Promising Results

Published: February 11, 2010

The XCell-Center has completed a promising safety follow-up of 870 patients who were treated by lumbar puncture for various indications such as spinal cord injury, Parkinson’s disease, cerebral palsy, and more. Patients were surveyed 10 days after treatment and again after 3 months.

The XCell-Center Treats its 2000th Stem Cell Patient in Germany

Published: December 21, 2009

The XCell-Center is pleased to report treating its 2000th stem cell patient at its state-of-the-art clinic in Dusseldorf, Germany.

Dusseldorf, Germany (PRWEB) December 21, 2009 — The XCell-Center is pleased to report treating its 2000th stem cell patient at its state-of-the-art clinic in Dusseldorf, Germany.